Navigation Links
Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine
Date:12/23/2008

Smokers who have an easier time quitting may have the benefit of specific genes that can foster success, according to a new study by a team of federal scientists at the National Institute on Drug Abuse.

Manhasset, NY (Vocus) December 23, 2008 -- Smokers who have an easier time quitting may have the benefit of specific genes that can foster success, according to a new study by a team of federal scientists at the National Institute on Drug Abuse. Tomas Drgon, Dean Hamer, George Uhl and their colleagues conducted genome-wide association studies on volunteers with smoking histories and symptoms of nicotine dependence, who were able to successfully stop smoking in community settings, "outside of the somewhat artificial setting of a clinical trial," the authors wrote. The subjects had a specific SNP, single nucleotide polymorphism, which made it easier to stop smoking and remain abstinent. There were SNPs that were more common among those who had trouble quitting and those who stopped without much trouble. In short, subjects who smoke or have smoked had a different genetic allele frequency than those who never smoked. Other researchers have also found similar patterns in genome-wide association studies with cigarettes and other drugs of abuse - a phenotype of substance dependence.

The authors did not find genetic linkage in social smokers (people who smoked at low and steady levels but who were not dependent on cigarettes).

These findings are "reassuring for future attempts to use genotype-based data to match smokers with the type and/or intensities of treatments that provide the best and most cost-effective smoking cessation opportunities for them in community settings," the authors wrote.

Other studies in the January-February 2009 issue of Molecular Medicine include ''Transcriptional Control of Chronic Fatigue Syndrome'' and ''Human AM/AMBP1 as a Treatment for Sepsis.''

Molecular Medicine is published by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. To read the journal online and view this month's popular podcast go to www.molmed.org. For more information contact Assistant Editor, Veronica Davis at 516-562-2670.

###

Read the full story at http://www.prweb.com/releases/Molecular/Medicine/prweb1789394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
2. Genome-wide Association Studies Must Account for Ancestry
3. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
4. Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkins Lymphoma
5. Dismissed leukemia drug helps cll patients, studies show
6. Studies examine quality of care for hospitalized sickle cell disease patients
7. FRC: New Mental Health Studies Dispel Myth That Abortion Is A Non-Event
8. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
9. Journal CHEST: December highlighted studies
10. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
11. MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 
(Date:2/11/2016)... ... February 11, 2016 , ... The book, “Computers Should Just Work!”, provides a ... ask your IT consultant before signing a contract and how to spot an incompetent ... companies relying heavily on e-mail and technology, it’s more important than ever to make ...
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s ... gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by ... honored to support a promising young investigator from Dr. Lengyel’s lab at the University ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual ... Imaging Congress (WMIC), will be held in New York City, NY on September ... Therapy.” The congress will highlight and emphasize how imaging reveals a greater understanding ...
(Date:2/10/2016)... New York, NY (PRWEB) , ... February 10, 2016 , ... ... a campaign to celebrate and raise awareness of Nestlé KITKAT as the first global ... improve the lives of cocoa farmers and the quality of their product, through activities ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... a full-service health care communications company offering education, research and medical media, ... practitioners and specialists working in infectious diseases. , As the all-inclusive resource ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...   Genomic Health, Inc. (Nasdaq: GHDX ) today ... ended December 31, 2015. --> --> ... compared with $69.1 million in the fourth quarter of 2014, an ... 9 percent compared with the same period in the prior year. ... $63.9 million in the fourth quarter of 2015, an increase of ...
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial ... --> --> Financial ... $9.45 billion, up 28% on a constant currency basis ... billion. Excluding the impact of the acquisition of Abbott ... (the "EPD Business"), full year adjusted total revenues increased ...
(Date:2/10/2016)... , Feb. 10, 2016 CSI Specialty ... with the launch of the Specialty Pharmacy Podcast. A ... industry-first, aimed at providing real-world education, discussion and context ... --> --> The Specialty ... CEO of CSI Specialty Group Suzette DiMascio, CHE, CMCE, ...
Breaking Medicine Technology: